Shengjie Bian

431 citations
10 papers · 359 indexed · h-index 8
Topics
Advancements in Transdermal Drug Delivery (2 papers)Drug Transport and Resistance Mechanisms (2 papers)Receptor Mechanisms and Signaling (2 papers)

In The Last Decade

Shengjie Bian

10 papers receiving 353 citations

Peers

Shengjie Bian
Comparison fields: 5 of 83
  • Molecular Biology 142
  • Pharmaceutical Science 85
  • Pulmonary and Respiratory Medicine 81
  • Biomedical Engineering 40
  • Oncology 39
Replace Jigar Lalani with:
Jigar Lalani India
Hongxia Lin South Korea
Romain Brusini France
Nagendra Chemuturi United States
Ahmed B. Ibrahim Egypt
John R. Mabus United States
Ola Camber Sweden
Tracey Boyden United States
Yongqiang Zhou China
Johanna J. Salomon Germany
Shengjie Bian relative to Jigar Lalani India Jigar Lalani's profile →
Citations per field
00.5×1.5×2.1×
Jigar Lalani · 1×
Citations per year

Countries citing papers authored by Shengjie Bian

Since Specialization
Citations

This map shows the geographic impact of Shengjie Bian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengjie Bian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengjie Bian more than expected).

Fields of papers citing papers by Shengjie Bian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengjie Bian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengjie Bian. The network helps show where Shengjie Bian may publish in the future.

Co-authorship network of co-authors of Shengjie Bian

This figure shows the co-authorship network connecting the top 25 collaborators of Shengjie Bian. A scholar is included among the top collaborators of Shengjie Bian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengjie Bian. Shengjie Bian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 6
2 3
3 26
4 51
5 16
6 15
7 77
8 134
9 13
10 18

About Shengjie Bian

Shengjie Bian is a scholar working on Pharmaceutical Science, Immunology and Allergy and Cell Biology, having authored 10 papers that have together received 359 indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Receptor Mechanisms and Signaling (2 papers). The work is most often cited by research in Pharmaceutical Science (85 citations), Pulmonary and Respiratory Medicine (81 citations) and Molecular Biology (142 citations). Shengjie Bian has collaborated with scholars based in South Korea, United States and Germany. Frequent co-authors include Dae‐Duk Kim, Suk-Jae Chung, Chang‐Koo Shim, Hongxia Lin, Hong Li, Andrew L. Harris, Jung‐Sun Kim, Hong Li, Hyun‐Jong Cho and Darren Locke. Their work appears in journals such as Biochemical Journal, Brain Research and Molecular Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026